STUDY OF POSSIBLE RISK FACTORS FOR ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE IN THE REPUBLIC OF BASHKORTOSTAN

  • Authors: Akhmadeeva G.N1,2, Tayupova G.N3, Bajtimerov A.R4, Magzhanov R.V4, Hidijatova I.M5, Husnutdinova J.K5
  • Affiliations:
    1. 1) Republic Clinical Hospital named after G.G. Kuvatov
    2. 2) Institute of Biochemistry and Genetics of Ufa science centre RAS
    3. Republic Clinical Hospital named after G.G. Kuvatov
    4. Bashkir State Medical University
    5. Institute of Biochemistry and Genetics of Ufa science centre RAS
  • Issue: Vol XLVII, No 1 (2015)
  • Pages: 27-31
  • Section: Articles
  • URL: https://journals.eco-vector.com/1027-4898/article/view/13903
  • DOI: https://doi.org/10.17816/nb13903
  • Cite item

Abstract


The features of anxiety and depressive disorders in patients with Parkinson’s disease in Republic of Bashkortostan according to sex, clinical form, age of onset, daily activities and the degree of movement disorders have been studied. It is found that anxiety and depressive disorders are prevalent in female patients. It is shown that the possible risk factors for anxiety and depressive disorders, in addition to a female, are low levels of daily activity and a high degree of motor impairment. Anxiety is significantly more often detected in patients with akinetic-rigid and rigid-trembling forms, and depression - in patients with akinetic-rigid-trembling form. Dependence on the age of manifestation was found only in men.

About the authors

Gulnara N Akhmadeeva

1) Republic Clinical Hospital named after G.G. Kuvatov; 2) Institute of Biochemistry and Genetics of Ufa science centre RAS

Email: nevrolog.ufa@gmail.com
1) 450005, Ufa, Dostoevskogo str., 132; 2) 450054, Ufa, Prospekt Oktjabrja, 71

Gulnaz N Tayupova

Republic Clinical Hospital named after G.G. Kuvatov

Email: nevrolog.ufa@gmail.com
450005, Ufa, Dostoevskogo str., 132

Azamat R Bajtimerov

Bashkir State Medical University

450000, Ufa, Lenina str., 3

Rim V Magzhanov

Bashkir State Medical University

450000, Ufa, Lenina str., 3

Irina M Hidijatova

Institute of Biochemistry and Genetics of Ufa science centre RAS

450054, Ufa, Prospekt Oktjabrja, 71

Jelza K Husnutdinova

Institute of Biochemistry and Genetics of Ufa science centre RAS

450054, Ufa, Prospekt Oktjabrja, 71

References

  1. Залялова З.А., Яковлева Л.А., Богданов Э.И. Немоторные проявления болезни Паркинсона: методическое пособие для постдипломного образования. Казань: КГМУ, 2009. 33 с.
  2. Залялова З.А., Хасанова Д.М. Депрессия при болезни Паркинсона / Болезнь Паркинсона и расстройства движений: руководство для врачей по материалам III Нац. конгресса. М., 2014. С. 90-93.
  3. Левин О.С. Болезнь Паркинсона как нейропсихиатрическое заболевание / Болезнь Паркинсона и расстройства движения: руководство для врачей по материалам II Нац. конгресса. М., 2011. С. 99-104.
  4. Шатова А.В. Нарушение когнитивных функций при болезни Паркинсона: Автореф. дисс. … канд. психол. наук. СПб, 2009. 161 с.
  5. Янакаева, Т.А. Сравнительный анализ когнитивных и аффективных расстройств при дисциркуляторной энцефалопатии, болезни Паркинсона и болезни Альцгеймера: Автореф. дисс.. канд. мед. наук. М., 1999. 22 с.
  6. Ardouin C., Lhomme E., Thobois S. et al. Piribedil improves apathy, depression and anxiety in Parkinson’s disease // Mov. Disord. 2009.Vol. 24 (Suppl. 1). S. 233.
  7. Beck A.T., Steer R.A., Ball R., Ranieri W.J. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients // Pers. Assess. 1996. Vol. 67, № 3. P. 588-597
  8. Cole S.A., Woodard J.L., Juncos J.L. et al. Depression and disability in Parkinson’s disease // J. Neuropsychiatry Clin. Neurosci. 1996. № 8. P. 20-25.
  9. Cummings J.L. Depression in Parkinson‘s disease // Am. J. Psychiatry. 1992. Vol. 149. P. 443-454.
  10. Fahn S., Elton R.L. UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale / Recent Developments in Parkinson’s Disease [eds. S.Fahn, C.D.Marsden, D.Calne, M. Goldstein]. Macmillan Health Care Information. Florham Park, N.J., 1987. P. 153-163.
  11. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality // Neurology. 1967. Vol. 17. P. 427-442.
  12. Hughes A.J., Daniel S.E., Blankson S., Lees A.J. A clinicopathological study of 100 cases of Parkinson‘s disease // Arch. Neurol. 1992. Vol. 50. P. 140-148.
  13. Leentjens A.F.G. Depression in Parkinson’s disease: conceptual issues and clinical challenges // J. Geriatr. Psychiatry Neurol. 2004. Vol. 17. P.120-126.
  14. Lindvall O., Rehncrona S., Brundin P. et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson‘s disease. A detailed account of methodology and a 6-month follow-up // Arch. Neurol. 1989. Vol. 46, № 6. P. 615-631.
  15. Shrag A. Psychiatric aspects of Parkinson’s disease // J. Neurol. 2004. Vol. 251. P. 795-804.
  16. Spielberger C.D., Gorsuch R.L., Lushene R. et al. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press, 1983.
  17. Starkstein S.E., Preziosi T.J., Bolduc P.L. et al. Depression in Parkinson’s disease // J. Nerv. Ment. Dis. 1990. Vol. 178. P. 27-31.
  18. Starkstein S.E., Merello M., Jorge R. et al. A validation study of depressive syndromes in Parkinson’s disease // Mov. Disord. 2008. Vol. 23, № 4. P. 538-546.
  19. Tandberg E., Larsen J.P., Aarsland D., Cummings J.L. The occurrence of depression in Parkinson’s disease. A community-based study // Arch. Neurol. 1996. Vol. 53. P. 175-179.
  20. Schwab R.S., England Jr. A.C. Projection techniques for evaluating surgery in Parkinson’s Disease / Third Symposium on Parkinson’s Disease, Royal College of Surgeons in Edinburgh, May 20-22, 1968 [eds. I.M.L. Gillingham, E. Donaldson. S.]. Livingstone Ltd, 1969. P. 152-157.

Statistics

Views

Abstract - 39

PDF (Russian) - 15

Cited-By


PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2015 Akhmadeeva G.N., Tayupova G.N., Bajtimerov A.R., Magzhanov R.V., Hidijatova I.M., Husnutdinova J.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies